|
iC9-CAR.B7-H3 T Cell Therapy Clinical Trials
1 actively recruiting trial across 1 location
Also known as: iC9-CAR.B7-H3 T cells
Chapel Hill, North Carolina1 trial
Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells
University of North Carolina
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.